A new way for a new world
Glenmark is focused on developing and marketing branded and generic formulations. The Formulations Business of Glenmark spans across various geographies primarily US, India, Europe, Latin America and Rest of the World. We focus on manufacturing niche products across therapeutic areas of dermatology, respiratory and oncology. Glenmark has 11 manufacturing facilities across India, the US and Czech Republic approved by regulatory bodies including U.S. FDA, MHRA UK and ANVISA BRAZIL. Being a research oriented organization Glenmark has invested in dedicated R&D centres for global markets.